Scalp Psoriasis Clinical Trial
Official title:
Comparison of the Maintenance Effect of Clobex® Shampoo 0.05% Used Twice Weekly vs. Vehicle on Scalp Psoriasis in Subjects Who Successfully Responded to a 4-week Daily Course of Clobex® Shampoo 0.05%
The objective of the study was to assess the maintenance effect on scalp psoriasis of Clobex® Shampoo 0.05% when used twice weekly.
Psoriasis was a chronic disease that was affecting skin, the scalp and joints. Scalp psoriasis was very common and was having an important impact on people's life. Primary objective of scalp psoriasis treatments was to gain initial and rapid control of the disease process with a minimum of side-effects and improve patient quality of life. Still, one of the unmet needs of scalp psoriasis therapies was the maintenance of a long-term remission. For corticosteroids in particular, one of the drawbacks was the disease recurrences after cessation of the treatment. Therefore, the establishment of a modified corticosteroid dosing regimen that would allow remission with minimal side-effects was suitable. The purpose of this study was to assess how long a patient successfully maintained in a good condition after use of Clobex® shampoo only twice a week. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01195831 -
Efficacy and Safety of Xamiol® Gel Compared to Calcipotriol Scalp Solution in Patients With Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT03880357 -
To Evaluate the Therapeutic Equivalence and Safety in Treatment of Scalp Psoriasis
|
Phase 1 | |
| Completed |
NCT03331523 -
To Study Generic Calcipotriene and Betamethasone Dipropionate Topical Suspension, 0.005%/0.064%, in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT04801433 -
Evaluate the Efficacy and Safety of Boroda Supramolecular Active Zinc in the Treatment of Scalp Psoriasis
|
N/A | |
| Completed |
NCT01120223 -
Safety and Efficacy of LEO 80185 Gel in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis
|
Phase 2 | |
| Completed |
NCT03897088 -
Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02932462 -
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02933866 -
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT05872256 -
A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis
|
Phase 4 | |
| Active, not recruiting |
NCT05272150 -
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02933502 -
Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product
|
Phase 2 | |
| Completed |
NCT01052467 -
Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)
|
N/A | |
| Completed |
NCT04243486 -
A Study of the Safety and Efficacy of UHE-105 Shampoo in Subjects With Scalp Psoriasis
|
Phase 2 | |
| Recruiting |
NCT02749656 -
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
|
Phase 3 | |
| Completed |
NCT02078297 -
IL-17 Role in Variants of Psoriasis
|
N/A | |
| Completed |
NCT00438399 -
Subject Preference for Scalp Psoriasis Treatment
|
Phase 3 | |
| Completed |
NCT05028582 -
Topical Roflumilast to Treat Scalp and Body Psoriasis (ARRECTOR)
|
Phase 3 | |
| Completed |
NCT01914627 -
Parallel Group Trial to Evaluate the Efficacy and Safety of Loion® Compared to 10% Salicylic Acid in Patients With Chronic Psoriasis Capitis
|
Phase 2 | |
| Not yet recruiting |
NCT01558310 -
A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis
|
Phase 4 | |
| Recruiting |
NCT05969223 -
Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp Psoriasis
|
Phase 4 |